GLABF

Gemina Laboratories Ltd.

USD

Set alert

Price alert · GLABF

All alert types
0.05 USD 0.00 0.00%
As of Oct 29, 2026
0.04 Day range 0.06
0.0375 52-week range 0.3439
YTD
0.00%
1 year
-85.46%
Open
0.06
Prev close
0.05
Mkt cap
3.83M
Vol
244.00K
Avg vol
0
EPS
-0.03
P/E
0.00
More statistics
Low
0.04
High
0.06

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for GLABF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-29.17 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -2.2×
FY 2020: -32.5×FY 2021: -5.4×FY 2022: -7.0×FY 2023: -7.8×FY 2024: -11.6×FY 2025: -2.2×
FY 2020 5y median -7.0× FY 2025
P/S 241×
FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 241×
FY 2020 5y median 0.0× FY 2025
P/B -0.9×
FY 2020: 169×FY 2021: 26.9×FY 2022: -585×FY 2023: -25.8×FY 2024: -10.7×FY 2025: -0.9×
FY 2020 5y median -10.7× FY 2025
P/FCF -10.0×
FY 2020: -84.9×FY 2021: -6.6×FY 2022: -9.2×FY 2023: -12.4×FY 2024: -36.4×FY 2025: -10.0×
FY 2020 5y median -10.0× FY 2025
EV/EBITDA -2.7×
FY 2020: -41.5×FY 2021: -5.2×FY 2022: -7.1×FY 2023: -8.1×FY 2024: -12.8×FY 2025: -2.7×
FY 2020 5y median -7.1× FY 2025
EV/Sales 279×
FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 279×
FY 2020 5y median 0.0× FY 2025
FCF Yield -10.0%
FY 2020: -1.2%FY 2021: -15.3%FY 2022: -10.9%FY 2023: -8.0%FY 2024: -2.7%FY 2025: -10.0%
FY 2020 5y median -10.0% FY 2025

Profitability

Gross Margin -74.4%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -74.4%
FY 2020 5y median 0.0% FY 2025
Operating Margin -10407.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -10407.0%
FY 2020 5y median 0.0% FY 2025
Net Margin -10893.2%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -10893.2%
FY 2020 5y median 0.0% FY 2025
ROE 39.2%
FY 2020: -521.5%FY 2021: -501.5%FY 2022: 8326.1%FY 2023: 329.1%FY 2024: 91.9%FY 2025: 39.2%
FY 2020 5y median 91.9% FY 2025
ROIC 47.8%
FY 2020: -250.1%FY 2021: -478.1%FY 2022: -3537.9%FY 2023: 462.4%FY 2024: 123.7%FY 2025: 47.8%
FY 2020 5y median 47.8% FY 2025
ROA -144.4%
FY 2020: -33.0%FY 2021: -333.4%FY 2022: -318.9%FY 2023: -358.2%FY 2024: -283.2%FY 2025: -144.4%
FY 2020 5y median -318.9% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 FY 2025
Operating Income 42.8%
FY 2020: 0.0%FY 2021: -633.3%FY 2022: -26.3%FY 2023: 15.0%FY 2024: 23.1%FY 2025: 42.8%
FY 2020 FY 2025
EPS (diluted) 44.2%
FY 2020: 0.0%FY 2021: -498.8%FY 2022: 0.1%FY 2023: 27.5%FY 2024: 23.6%FY 2025: 44.2%
FY 2020 FY 2025
Free Cash Flow 60.1%
FY 2020: 0.0%FY 2021: -1116.4%FY 2022: -18.2%FY 2023: 28.4%FY 2024: 60.4%FY 2025: 60.1%
FY 2020 FY 2025

Financial Health

Current Ratio 0.1×
FY 2020: 1.1×FY 2021: 2.9×FY 2022: 0.3×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.1×
FY 2020 5y median 0.1× FY 2025
Quick Ratio 0.1×
FY 2020: 0.4×FY 2021: 2.9×FY 2022: 0.3×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.1×
FY 2020 5y median 0.1× FY 2025
Debt / Equity -0.2×
FY 2020: 0.6×FY 2021: 0.0×FY 2022: -3.4×FY 2023: -0.3×FY 2024: -0.3×FY 2025: -0.2×
FY 2020 5y median -0.3× FY 2025
Net Debt / EBITDA -0.4×
FY 2020: 1.2×FY 2021: 0.2×FY 2022: -0.0×FY 2023: -0.1×FY 2024: -0.3×FY 2025: -0.4×
FY 2020 5y median -0.1× FY 2025
Interest Coverage -32.1×
FY 2020: -261×FY 2021: -8784×FY 2022: 0.0×FY 2023: -264×FY 2024: -23.8×FY 2025: -32.1×
FY 2020 5y median -32.1× FY 2025

Dividends

Dividend Yield 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2026-01-31